Author:
Wang Xu,Shen Ke,Lu Fang,He Shigang
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology
Reference55 articles.
1. Arámbulo, O., Dib, G., Iturralde, J., Duran, F., Brito, M., and Fortes Filho, J.B. (2015). Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity. Clin Ophthalmol 19, 2027–2032.
2. Bossi, E., and Koerner, F. (1995). Retinopathy of prematurity. Intensive Care Med 21, 241–246.
3. Chen, M., Weng, S., Deng, Q., Xu, Z., and He, S. (2009). Physiological properties of direction-selective ganglion cells in early postnatal and adult mouse retina. J Physiol 587, 819–828.
4. Chung, E.J., Kim, J.H., Ahn, H.S., and Koh, H.J. (2007). Combination of laser photocoagulation and intravitreal bevacizumab (Avastin®) for aggressive zone I retinopathy of prematurity. Graefe’s Arch Clin Exp Ophthalmol 245, 1727–1730.
5. Connor, K.M., Krah, N.M., Dennison, R.J., Aderman, C.M., Chen, J., Guerin, K.I., Sapieha, P., Stahl, A., Willett, K.L., and Smith, L.E.H. (2009). Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4, 1565–1573.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献